A Predictive Model of New-Onset Atrial Fibrillation After Percutaneous Coronary Intervention in Acute Myocardial Infarction Based on the Lymphocyte to C-Reactive Protein Ratio.

"Disclosure The authors declare that they have no known competing financial interests or personal relationships that could appear to influence the work reported in this paper."

"This study was supported by the National Natural Science Foundation of China (No. 81670447), the Medicine and Health Project of Zhejiang Province (No. 2023KY531) and the Traditional Chinese Medicine Program of Zhejiang Provincial (No. 2022ZZ003, No. 2023ZL248, 2022ZB024). LW was sponsored by Ten-thousand Talents Program of Zhejiang Province (No. 2021R52025)."

"Ethics Approval and Informed Consent: This study protocol was reviewed and approved by the Institutional Review Committee of the Zhejiang Provincial People’s Hospital, registration number: QT2023256. Informed consent was waived due to the retrospective nature of the study. At the same time, patient data was anonymized or maintained with confidentiality and this study was in line with the Declaration of Helsinki."